65
Participants
Start Date
May 14, 2015
Primary Completion Date
May 28, 2020
Study Completion Date
May 28, 2020
PF-06747775
Palbociclib
Avelumab
Chris O'Brien Lifehouse, Camperdown
Royal Prince Alfred Hospital, Camperdown
Prince Charles Hospital, Cancer Care Services, Chermside
UPMC Cancer Pavilion, Pittsburgh
UPMC Hillman Cancer Center, Pittsburgh
UC San Diego Medical Center - La Jolla, La Jolla
UC San Diego Moores Cancer Center, La Jolla
UC San Diego Medical Center - Hillcrest, San Diego
Seattle Cancer Care Alliance, Seattle
Smilow Cancer Hospital at Yale-New Haven, New Haven
National Hospital Organization Shikoku Cancer Center, Matsuyama
The Cancer Institute Hospital of JFCR, Koto-ku, Tokyo
Seoul National University Hospital / Department of Internal Medicine, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Lead Sponsor
Pfizer
INDUSTRY